May 16, 2020

Shapeways and Stratasys combine in 3D printing joint venture

Shapeways
3D Printing
Stratasys
Technology
Sean Galea-Pace
1 min
The leading 3D printing service and marketplace, Shapeways, has announced a joint venture with US-based Stratasys, which will see the duo provide design...

The leading 3D printing service and marketplace, Shapeways, has announced a joint venture with US-based Stratasys, which will see the duo provide designers and creators with easier access to full-colour multi-material 3D printing.

The new service is inspired from one of the only full-colour, multi-material 3D printers in the world: the Stratasys J750, which the companies anticipate will bring the full potential of the printer to a wider market.

It is hoped the printer will reduce time-to-market and time-to-revenue, in addition to allowing designers and engineers to create highly realistic prototypes with efficient design-to-prototype workflows.

See more:

Greg Kress, CEO of Shapeways, said: “The vivid colours of the Stratasys J750 3D Printer will enable the Shapeways community of designers, businesses, students, and artists to realize their brightest ideas and boldest ambitions in true physical form with full-colour, texture mapping and colour gradients.”

“It’s exactly what our customers have been asking for.”

The Stratasys J750 3D Printer provides over 500,000 colour combinations, highly accurate colour-matching, transparent to opaque colour gradients, and advanced clear material with texture to enable the printer to come to life.

Share article

Jun 8, 2021

IMF: Variants Can Still Hurt Manufacturing Recovery

IMF
Manufacturing
COVID19
Musk
Elise Leise
3 min
The International Monetary Fund (IMF) claims that while markets are rising and manufacturing is coming back, it’ll push for global immunisation

After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022

Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery. 

Lingering Concerns Over COVID

Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high. 

Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery? 

IMF: Current Boom Could Falter

Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”. 

Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”. 

Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.

Share article